What the business is, and whether it's a good one at a fair price.
A Healthcare Equipment & Supplies company listed on BSE, reporting revenue of ₹56 Cr over the trailing twelve months.
Measured from the filed financials, judged against its Medical Equipment & Supplies peers · as of FY26 — not investment advice
How has the market priced it — with filings on the timeline?
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
How does it stack up on valuation, returns and growth?
Loading peers…
Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.
Loading financials…
Who owns it — and is the promoter stake clean?
Loading shareholding…
Sign up to see the full company file
Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.
Answered from CENTENIAL SURGICAL SUTURE LTD.'s filed financials and exchange disclosures
CENTENIAL SURGICAL SUTURE LTD. is a Healthcare Equipment & Supplies company listed on BSE.
No. Over the trailing twelve months CENTENIAL SURGICAL SUTURE LTD. reported a net loss of ₹1 Cr on revenue of ₹56 Cr.
Not in the latest reported year — CENTENIAL SURGICAL SUTURE LTD.'s dividend payout for FY26 was nil.
No. Debt stands at 0.38× equity, and it carries net debt of ₹11 Cr. That is lower than 10% of its 11 Medical Equipment & Supplies peers.
On trailing P/E, CENTENIAL SURGICAL SUTURE LTD. ranks 4 of 17 in Medical Equipment & Supplies — cheaper than 81% of them, against an industry median of 20.0×. This is a position, not a valuation judgement.
On a typical session CENTENIAL SURGICAL SUTURE LTD. moves 2.96% — that is the median absolute close-to-close move across its last 221 trading days. Announcement days are routinely larger.
Every NSE and BSE filing by CENTENIAL SURGICAL SUTURE LTD. appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.
Figures are as last reported and may lag the latest filing. Not investment advice.
